Skip to main content
. 2022 Oct 20;12(10):1745. doi: 10.3390/jpm12101745
BC bladder cancer
BCG bacillus Calmette-Guerin
CIS carcinoma in situ
GC gemcitabine cisplatin
ICI immune checkpoint inhibitor
IO immuno-oncology
MIBC muscle-invasive bladder cancer
MVAC methotrexate, vincristine, adriamycin, and cisplatin
NMIBC non-muscle invasive bladder cancer
RC radical cystectomy
TKI tyrosine kinase inhibitor
TMT trimodal therapy
TURBT transurethral resection of bladder tumor
UC urothelial cancer